follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Cancer Genetics Inc. announces IPO pricing

By

Back to Top Comments Email Print

Latest News

advertisement

Rutherford-based Cancer Genetics Inc., a diagnostics company focused on oncology tests and services, today announced the pricing of its initial public offering of 600,000 shares of its common stock at $10 per share.

The gross proceeds to Cancer Genetics from the initial public offering are expected to be $6 million. The offering is expected to close April 10, subject to customary closing conditions, the company announced.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top